[e-drug] GlaxoSmithKline aims to stop ARV reimportation (2)

["Murtada Sesay" <msesay@unicef.org>]

E-DRUG: GlaxoSmithKline aims to stop ARV reimportation (2)
------------------------------------------

Dear E-Druggers,

Sometimes one cannot help but wonder whether and/or when this battle will
ever be won! On the one hand, whilst we laud the efforts of all, including
donors and local advocates, in improving access to life-saving medicines
for poor countries, on the other, we hear of alleged practices which negate
such efforts. But a valid question should be; why is it that only
"givers" appear to be pro active, whilst there appears to be little or no
sensibility or concerns from the "takers", especially governments who have
the primary responsibility for their peoples health and productivity? So,
whilst I personally see no problem with benevolent companies taking action
to protect the value of their donations, and perhaps also justifiably
protect their businesses, we would like to hear more of what actions
beneficiaries, especially governments, are taking to investigate and take
appropriate actions against such serious allegations. I think the time has
come for naming and shaming! Let us also remember that smuggling is an
underground activity. Thus, whilst physical appearances can help trace
smuggled items, this is no guarantee for significant reduction.
By the way, is it really accurate to say that a drug which has had a "red
dye" incorporated has the same chemical identity with another which has no
such dye?

Murtada M. Sesay
Technical Officer (Pharmaceuticals)
UNICEF Supply Division

Tel: +45 3527 3098
Mobile: +45 28 23 28 07
E-mail: msesay@unicef.org
Web: www.unicef.org/supply
_____________________________________

For every child
Health, Education, Equality, Protection
ADVANCE HUMANITY